Aging and drug discovery

Next generation sequencing technologies for aging and drug discovery - Alla Lapidus

New biomarkers and interventions in aging - Alexey Moskalev

Artificial intelligence and blockchain in healthcare

The Gene-Chain, a commercial blockchain genomics platform - Maurizio Viviani

Exonum framework for blockchain projects in Healthcare - G. Givishvili

How can pharmaceutical R&D learn from cats and cars? - V. de Biasi

Deep learning in Computational Pathology - Thomas J. Fuchs

Blockchains for genome data management - Daniel Burgwinkel

Blockchains in production use in healthcare - I. Lomus

http://www.professionalabstracts.com/basellife2017/planner/index.php?go=abstract&action=abstract_show&absno=460&

Basel Agenda

Basel Agenda 2017 - Beatus Hofrichter

New models in ppp rising - B. Pécoul

Biotherapeutics

Open-source antigens and antibodies from the institute for protein innovation - James Love

Thermal stabilization and conformational trapping of membrane transporters by in vitro selected synthetic nanobodies - M. Seeger

Digital biomarkers

Digital biomarkers for neurological disorders - Ray Dorsey

Medicinal Chemistry

Screening small-molecule libraries for Gram negative active compounds. Opportunities and pitfalls - Daniel Ritz

Biophysics in drug discovery - Michael Hennig

Microfluidics

Picking the right microfluidics device material for in vitro diagnostics - balancing performance and cost with glass - Alexios Paul Tzannis

Advanced ceramics: a high performance option for microfluidics? - Senad Hasanovic

Innovating MedComms

Reproducibility and reuse of scientific code - Pierre Montagano

NGS

ReneGENE: a pipeline to maximally harness the genome big-data - Debnath Pal

What´s in a name? An NGS method naming explosion! - James Hadfield

Transitioning from gene panels to exome sequencing for diagnostic testing - Sami Amr

Peptide Therapeutics

Palladium in peptide/protein synthesis and modification - Ashraf Brik

Synthetically difficult peptide therapeutics: increasing purity and yield of SPPS using parallel synthesis optimization - Andrew Kennedy

Artificial intelligence designed TLR4 peptide activators - Amit Michaeli

Rapid Fire Session

Network analysis of induced pluripotent stem cells secretome indicate reveals macrophage dependent anti fibrotic action in rat lung injury model - Cedric Simillion

High-Content Assay for Morphological Characterization of 3D Neuronal Networks in Microfluidic Platform - Oksana Sirenko

Blockchain-Enabled Open Data Framework Fostering Collaborative Research - Sebastian Bürgel

Biofabrication of 3D tissue models by assembling cell-laden hydrogel units - Shintaroh Iwanaga

Stem Cells

A resource of conditional knockouts in human stem cells - Bill Skarnes

An iPSC patient specific model of CFH (Y402H) polymorphism displays characteristic features of AMD and indicates a beneficial role for UV light exposure - Dean Hallam

Introduction of desired mutations in human pluripotent stem cells and the spectre of undesired culture-acquired mutations - Florian Merkle

Modelling neuroinflammation using human induced pluripotent stem cell-derived microglia - Sally Cowley